Glaukos Announces Licensing Agreement with Attillaps Holdings, Inc; Attillaps Has Granted Glaukos An Exclusive License To Research, Develop, Manufacture And Commercialize Attillaps' Proprietary Library Of Investigational Pharmaceutical Compounds That Target The Eradication Of Demodex Mites